Guardant Health
GH
#3559
Rank
โ‚ฌ2.78 B
Marketcap
22,64ย โ‚ฌ
Share price
-1.18%
Change (1 day)
-11.96%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚ฌ1.21 B

According to Guardant Health 's latest financial reports the company's total debt is โ‚ฌ1.21 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ1.22 B-4.07%
2022-12-31โ‚ฌ1.27 B5.72%
2021-12-31โ‚ฌ1.20 B72.74%
2020-12-31โ‚ฌ0.69 B1842.98%
2019-12-31โ‚ฌ35.97 M
2018-12-31N/A-100%
2017-12-31โ‚ฌ0.54 M-96.61%
2016-12-31โ‚ฌ16.19 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
โ‚ฌ0.39 B-67.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.80 B-33.57%๐Ÿ‡บ๐Ÿ‡ธ USA